Safety and efficacy of damoctocog alfa pegol prophylaxis in patients with severe haemophilia A: Results of an interventional, post-marketing study

Pål André Holme, Lone Hvitfeldt Poulsen, Claudia Tueckmantel, Monika Maas Enriquez, María Teresa Alvarez Román, Raimondo De Cristofaro*

*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivista › Articolo in rivista › peer review

Fingerprint

Entra nei temi di ricerca di 'Safety and efficacy of damoctocog alfa pegol prophylaxis in patients with severe haemophilia A: Results of an interventional, post-marketing study'. Insieme formano una fingerprint unica.

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology